WO2015089465A1 - Delivery, use and therapeutic applications of the crispr-cas systems and compositions for hbv and viral diseases and disorders - Google Patents
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors
How Crispr went from niche to Nobel | Feature | Chemistry World
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
PDF) Scalable Package Queries in Relational Database Systems
Epigenetic Segregation of Microbial Genomes from Complex Samples Using Restriction Endonucleases HpaII and McrB | PLOS ONE
Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus | PNAS
Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus | PNAS
(PDF) Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo
PDF) C U R I O U S CURRENT AFFAIRS YEARLY COMPILATION | Gaurav Sharma - Academia.edu
Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13 | ACS Synthetic Biology
Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo - Abstract - Europe PMC
Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo | Nature Communications
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13 | ACS Synthetic Biology
Precision Cas9 Genome Editing in vivo with All-in-one, Self-targeting AAV Vectors | bioRxiv
Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13 | ACS Synthetic Biology
Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo | Nature Communications
Humankind 2.0: The Technologies of the Future 6. Biotech
How Crispr went from niche to Nobel | Feature | Chemistry World
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
Bacterial N4-methylcytosine as an epigenetic mark in eukaryotic DNA | Nature Communications
How Crispr went from niche to Nobel | Feature | Chemistry World
